Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 4, Pages 1090
Publisher
MDPI AG
Online
2018-04-06
DOI
10.3390/ijms19041090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
- (2017) David Planchard et al. LANCET ONCOLOGY
- BRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis
- (2017) Huy Gia Vuong et al. MOLECULAR NEUROBIOLOGY
- RARE-35. DABRAFENIB IN PATIENTS WITH RECURRENT, BRAF V600E MUTATED MALIGNANT GLIOMA AND LEPTOMENINGEAL DISEASE
- (2017) Michael Burger et al. NEURO-ONCOLOGY
- BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma
- (2017) Denis Migliorini et al. NEUROLOGY
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
- (2016) Felix Behling et al. Diagnostic Pathology
- Successful Treatment of a ProgressiveBRAFV600E–Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy
- (2016) Eudocia Q. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
- (2016) Jie Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Personalized Treatment for a Patient With aBRAFV600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma
- (2016) Silviya K. Meletath et al. Journal of the National Comprehensive Cancer Network
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation
- (2015) Bette K. Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
- (2015) Sanda Alexandrescu et al. BRAIN PATHOLOGY
- Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAF V600E mutation
- (2015) Masayuki Kanamori et al. Brain Tumor Pathology
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma
- (2015) Jun-Ichiro Kuroda et al. NEUROPATHOLOGY
- Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation
- (2014) Shingo Tanaka et al. Brain Tumor Pathology
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- (2013) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- BRAF V600E Mutation Identifies a Subset of Low-Grade Diffusely Infiltrating Gliomas in Adults
- (2013) Andrew S. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
- (2013) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- BRAF-V600E mutation in pediatric and adult glioblastoma
- (2013) S. Dahiya et al. NEURO-ONCOLOGY
- Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma
- (2013) A. Broniscer et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Epithelioid Versus Rhabdoid Glioblastomas Are Distinguished by Monosomy 22 and Immunohistochemical Expression of INI-1 but not Claudin 6
- (2010) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- BRAF Signaling and Targeted Therapies in Melanoma
- (2009) Nathalie Dhomen et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search